Rock Health Capital Research
Investment Thesis
Rock Health Capital is a dedicated venture capital fund investing at the intersection of healthcare and technology, with a mission to make healthcare massively better for every human being. Founded by Bill Evans and built on over a decade of digital health market expertise through the parent Rock Health organization, the firm invests in remarkable entrepreneurs building technology-driven solutions that reshape healthcare delivery, patient outcomes, and the healthcare system at scale.
The fund believes that the most compelling opportunities exist where technology directly addresses healthcare's most pressing challenges—from clinical decision support to patient engagement, from workforce productivity to administrative efficiency. Rock Health's unique position allows them to combine deep healthcare domain expertise with access to the Rock Health community of 50,000+ digital health professionals and market leaders.
Stage and Focus
Rock Health Capital focuses exclusively on early-stage companies, targeting:
- Pre-Seed: $250K-$1M for teams with compelling vision and initial traction
- Seed: $500K-$5M for companies with product-market validation and strong founding teams
- Series A: Selective follow-ons for proven portfolio companies showing exceptional growth
The firm explicitly targets Seed and Series A companies but also participates in pre-seed rounds for exceptional teams with deep healthcare insights.
Check Size and Deal Structure
Typical investment range: $500K - $5M with the following characteristics:
- Seed checks: $1M-$3M typical ticket size
- Series A participation: Follows winners from seed round or leads new Series A rounds
- Leadership approach: Willing to lead seed rounds; often participates in Series A rounds led by other tier-1 investors
- Board seat policy: Typically takes observer or board seats in invested companies
Rock Health Capital maintains an active follow-on strategy with 50% of fund reserves dedicated to supporting winning portfolio companies through subsequent rounds.
Portfolio and Recent Activity
Rock Health Capital has deployed capital actively from Fund II (closed July 2023) across a diverse set of digital health companies spanning over 70+ portfolio companies including:
Recent Investments (2025):
- No Barrier AI (September 2025) - Language access in healthcare
- Ours Privacy (ongoing) - HIPAA-safe marketing and analytics
- Pear Suite (2025) - Community-based care infrastructure
- RxSaveCard (2025) - Employer pharmacy spend management
- Marigold Health (2024-2025) - Mental health and addiction recovery
- WellTheory (2024) - Autoimmune condition management
Portfolio Highlights: The portfolio spans multiple healthcare subsectors including:
- Clinical Decision Support: Ambient Clinical Analytics, CancerIQ, InsightRX
- Care Coordination: Collective Health, Welkin Health, Wellframe
- Patient Engagement: Omada Health, Honor, Equip, Kurbo Health
- Workforce Tools: Augmedix, drchrono, Kit Check, TelePharm
- Administrative Solutions: Ribbon Health, Moxe, Aptible, Reify Health
- Emerging AI/ML: No Barrier AI, Ours Privacy, Evidation Health
Fund status: Actively deploying from Fund II, with significant capital remaining. Last known significant activity: September 2025 (No Barrier AI investment).
Fund Size and Assets Under Management
Rock Health Capital Fund II closed in July 2023. While specific AUM figures are not publicly disclosed, the fund has demonstrated sustained deployment capacity with 70+ portfolio companies and continued active investment in 2025. Fund I was noted with approximately $13-15M in AUM based on SEC filings.
Team and Leadership
Bill Evans - Founder and General Partner
- Former Senior Director at Roche Diagnostics (oncology decision support, Navify)
- Multiple leadership roles at Genentech (biotechnology)
- Career started at Goldman Sachs before transitioning to software engineering in Silicon Valley (late 1990s)
- Harvard University BA in Economics
- Deep healthcare expertise combined with capital markets experience
Sean Day - Principal
- Previously on Consulting and Research teams at Rock Health
- Former Operations Analyst at Epic (population health R&D scaling)
- Union College BS Bioengineering (summa cum laude)
- Cambridge University Master's in Technology Policy
- Watson Fellowship recipient
- Extensive international research background in technology and healthcare
Advisors:
- Hylton Kalvaria
- Keith W. Anderson
- Monique Smith, MD
Rock Health Capital benefits from the deep network and expertise of the broader Rock Health ecosystem, including 50,000+ digital health professionals and market leaders.
Geographic and Sector Focus
Primary Geography:
- US Focus: San Francisco Bay Area, New York, Boston, Seattle
- Investment reach: National, with occasional international opportunities
Healthcare Sectors:
- Digital health across all segments (primary care, specialty care, behavioral health, dental, pharmacy, etc.)
- Healthcare IT and administrative solutions
- Patient engagement and outcomes platforms
- Workforce and clinical productivity tools
- Emerging AI/ML healthcare applications
Stage Vertical Mix:
- B2B healthcare software (dominant)
- Patient-facing digital health solutions
- Healthcare IT infrastructure and tools
- Provider workflows and clinical decision support
Decision Process and Timeline
- Decision Process: Partnership model with Bill Evans (General Partner) and Sean Day (Principal) leading investment decisions
- Timeline: Active engagement with companies, typically 4-8 weeks from initial conversation to term sheet
- Warm Introduction: Strongly preferred; Rock Health's position as market authority means founders often come through network connections
- Typical Involvement: Board observer seat or board seat in seed investments; observer rights in Series A follow-ons
Lead Tendency and Market Position
Rock Health Capital leads Seed rounds and participates in Series A rounds where they've been early investors. The firm's positioning as the most authoritative voice in digital health markets (through Rock Health advisory services and market research) means they often attract founder interest and can command board seats.
- Fund Activity: Actively deploying from Fund II
- Market Sentiment: 2025 saw $14.2B in digital health funding across 482 deals (35% YoY increase), the highest since 2022. Rock Health views this as a "tale of two markets" where capital concentrates among proven winners.
- Recent Market Observations: Q4 2025 marked highest quarterly digital health funding ($4.2B across 129 deals)
Founder Preferences and Anti-Thesis
Founder Preferences:
- Deep healthcare domain expertise (ideally clinical or healthcare operations background)
- Technical founders with proven execution
- Entrepreneurial focus on solving real healthcare problems
- Teams with healthcare customer intimacy and market understanding
Anti-Thesis:
- Purely consumer-facing health apps without medical differentiation
- Healthcare plays dependent on major pharma or provider relationships without independent value prop
- Teams without healthcare domain insight
Exit and LP Base
Rock Health Capital attracts institutional LPs interested in healthcare technology disruption. The fund's positioning as the leading digital health market authority (through Rock Health's research and advisory services) provides unique data insights and network effects for portfolio companies.
Limited information available on specific exits from Fund I, though the portfolio demonstrates durability and sustained enterprise value creation.
Notable Characteristics
-
Market Insight: Rock Health Capital uniquely benefits from Rock Health's position as the definitive digital health market research and advisory platform, giving portfolio companies privileged access to market data, trends, and insights
-
Community Access: Portfolio companies gain access to Rock Health's 50,000+ member community, providing user acquisition, partnership, and talent sourcing opportunities
-
Content and Visibility: Bill Evans regularly publishes quarterly and annual digital health market reports that shape industry narrative and investor sentiment
-
Hands-On Support: Beyond capital, the team provides strategic consulting, market research access, and intros to Rock Health's extensive healthcare executive network
-
Healthcare Pedigree: Combination of healthcare industry experience (Roche, Genentech, Epic) with venture capital mindset creates sophisticated healthcare investor base